AGEs, RAGE, and Diabetic Retinopathy (Q37876790)

24 August 2017

1 reference

title

AGEs, RAGE, and diabetic retinopathy (English)

1 reference

24 August 2017

AGEs, RAGE, and Diabetic Retinopathy (English)

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

advanced glycation end-product receptor activity

2 December 2024

main subject

1 reference

Gene Ontology release 2020-05-02

2

Micheal Ward

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21590515

2 December 2024

3

Alan W. Stitt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21590515

2 December 2024

author name string

Hongliang Zong

1

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21590515

2 December 2024

publication date

1 August 2011

1 reference

24 August 2017

August 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21590515

full work available at URL

2 December 2024

http://link.springer.com/content/pdf/10.1007/s11892-011-0198-7.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

http://link.springer.com/article/10.1007/s11892-011-0198-7/fulltext.html

2 December 2024

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

http://link.springer.com/content/pdf/10.1007/s11892-011-0198-7

2 December 2024

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

2 December 2024

published in

Current diabetes report

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

244-252

1 reference

AGEs and diabetic retinopathy.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Prevalence of diabetic retinopathy in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Management of diabetic retinopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Molecular enzymology of the glyoxalase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Advanced glycoxidation end products in commonly consumed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

ADME evaluation in drug discovery. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

The AGE-receptor in the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Identification, classification, and expression of RAGE gene splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

RAGE and its ligands: a lasting memory in diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

The RAGE axis in early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

M-1/M-2 macrophages and the Th1/Th2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

The choroidal circulation and retinal metabolism--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Advanced glycation end products increase retinal vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

PKC delta and NADPH oxidase in AGE-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Receptor for advanced glycation end product expression in experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

RAGE ligation affects T cell activation and controls T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Angiogenic growth factors and their inhibitors in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Anti-VEGF therapy in proliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

KIOM-79 prevents methyglyoxal-induced retinal pericyte apoptosis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Minodronate, a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts

21 January 2018

1 reference

12 December 2020

The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas

1 reference

12 December 2020

Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group

1 reference

12 December 2020

Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes

1 reference

12 December 2020

Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats

1 reference

12 December 2020

Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface

1 reference

12 December 2020

Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation

1 reference

12 December 2020

PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease

1 reference

12 December 2020

Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products

1 reference

12 December 2020

Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression

1 reference

12 December 2020

A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy

1 reference

12 December 2020

S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release

1 reference

12 December 2020

Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries

1 reference

12 December 2020

Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction

1 reference

12 December 2020

Advanced Glycation End Products Induce Expression of Vascular Endothelial Growth Factor by Retinal Müller Cells

1 reference

12 December 2020

Advanced glycation and retinal pathology during diabetes.

1 reference

12 December 2020

RAGE: a novel biological and genetic marker for vascular disease.

12

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).

2 December 2024

30

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands

2 December 2024

31

1 reference

https://api.crossref.org/works/10.1007/S11892-011-0198-7

2 December 2024

Identifiers

1 reference

24 August 2017

1 reference